Senior Vice President, Global Head Neuroscience Therapeutic Area Unit at Takeda Pharmaceutical International
NeRRe Therapeutics Ltd
Founder & Chief Executive Officer
December 2012 to December 2013
Stevenage, United Kingdom
1991 to 1995
Head of Biochemistry Department
1986 to 1991
SVP Neurosciences Drug Discovery
2000 to 2010
Head of Biochemistry Laboratory
1981 to 1986
Takeda Pharmaceutical Company Ltd
Head of CNS Drug Discovery Unit
Shonan Research Center, Japan
Takeda Pharmaceutical International
Senior Vice President, Head of CNS Therapeutic Area Unit
Deerfield, IL (USA)
Director Drug Discovery (Italy-Spain)
1995 to 2000
Founder & Chief Executive Officer @ NeRRe Therapeutics Ltd From December 2012 to December 2013 (1 year 1 month) Stevenage, United KingdomResearch Director @ Glaxo (Italy) From 1991 to 1995 (4 years) Head of Biochemistry Department @ Glaxo (Italy) From 1986 to 1991 (5 years) SVP Neurosciences Drug Discovery @ GlaxoSmithKline From 2000 to 2010 (10 years) Head of Biochemistry Laboratory @ Pierrel Research From 1981 to 1986 (5 years) Head of CNS Drug Discovery Unit @ Takeda Pharmaceutical Company Ltd Shonan Research Center, JapanSenior Vice President, Head of CNS Therapeutic Area Unit @ Takeda Pharmaceutical International Strategic and operational responsibility of the CNS and Immunology R&D pipeline from Candidate Selection to Registration and Life Cycle Management Deerfield, IL (USA)Director Drug Discovery (Italy-Spain) @ GlaxoSmithKline From 1995 to 2000 (5 years)
What company does Emiliangelo Ratti work for?
Emiliangelo Ratti works for NeRRe Therapeutics Ltd
What is Emiliangelo Ratti's role at NeRRe Therapeutics Ltd?
Emiliangelo Ratti is Founder & Chief Executive Officer
What industry does Emiliangelo Ratti work in?
Emiliangelo Ratti works in the Pharmaceuticals industry.
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
5 year(s), 0 month(s)
There's 71% chance that Emiliangelo Ratti is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies